Partner, admitted to the Paris Bar since 2002, Antoine Tézenas du Montcel is a member of the Mergers Acquisitions practice group. His practice covers mergers and acquisitions, company law and securities law. He mainly works on mergers and acquisitions, with a focus on listed companies. He also has experience in IPOs, securities offerings and private investments in public equity.
His recent assignments include advising Legrand on the acquisition of a majority stake in the listed company Debflex (2018); LFPI on acquiring a stake in the listed company Umanis (2018); Les Mousquetaires on the acquisition of Bricorama (2017); Debiopharm Holding on the sale of its stake in the listed property company Eurosic to Gecina (2017); Michelin on the simplified tender offer launched over SIPH (2017); Zimmer Biomet on its acquisition of a controlling stake in the listed company Medtech followed by a public tender offer on the remaining shares of Medtech (2016); Furui Medical on its investment in the listed company Median Technologies (2016); Tinavi Medical on its investment in the share capital of the listed company Spineway (2016); Debiopharm Holding on its investment in Eurosic (2016); HNA Tourism Group on its investment in the listed company Pierre & Vacances (2016); IDG Capital Partners on its investment in the listed company Parrot (2015); Cisco in the context of the sale of its Connected Devices division to the listed company Technicolor (2015); Groupe Visiodent on the simplified tender offer launched over Visiodent (2014); CNIM in the scope of the takeover bid initiated by Soluni (2014); Boursorama in the context of the simplified tender offer launched by Société Générale (2014).
He is a graduate of the University Paris II Assas with a Magistère de Juriste d'Affaires - D.J.C.E.